The CPMT morphology with EGFR‐KDD in the post‐therapy specimen might be an evolution induced by the treatment, which suggests the hypothesis that CPMT is part of the morphologic spectrum of infantile fibrosarcoma/cellular mesoblastic nephroma. The gene discussed is EGFR; the disease is fibrosarcoma.